Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients

References

• Angeli A, Gatti G, Masera R. Chronobiology of the hypothalamic‐pituitary‐adrenal and renin‐angiotensin‐aldosterone systems. Biologic Rhythms in Clinical and Laboratory Medicine, Y Touitou, E Haus. Springer‐Verlag, Berlin 1992; 292–314
   Google Scholar
• Anwar Y A, Giacco S, McCabe E J, Tendler B E, White W B. Evaluation of the efficacy of the Omron HEM‐737 Intellisense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press. Monit. 1998; 3: 261–265
   PubMedGoogle Scholar
• Bartter F C, Chan J CM, Simpson H W. Chronobiological aspect of plasma renin activity, plasma aldosterone and urinary electrolytes. Endocrine Rhythms, D T Krieger. Raven, New York 1979; 49–132
   Google Scholar
• Chrysant S G, Marbury T C, Robinson T D. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild‐to‐moderate hypertension. J. Hum. Hypertens. 2003; 17: 425–432
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen J A, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: The Dublin outcome study. Hypertension 2005; 46: 156–161
   PubMed Web of Science ®Google Scholar
• Fernández J R, Hermida R C. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 1998; 15: 191–204
   PubMed Web of Science ®Google Scholar
• Fernández J R, Mojón A, Hermida R C. Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 2004; 21: 467–482
   Web of Science ®Google Scholar
• Hermida R C. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rationale and design of the MAPEC study. Chronobiol. Int. 2007; 24: 749–775, for the MAPEC Study Investigators
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, López J E. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 2002; 20: 1097–1104
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Domínguez M J, Covelo M, Fernández J R, Mojón A, López J E. Administration‐time‐dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42: 283–290
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Domínguez M J, Covelo M, Fernández J R, Fontao M J, López J E. Administration‐time‐dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 2004; 21: 277–296
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Fernández J R, Covelo M, Mojón A, López J E. Treatment of non‐dipper hypertension with bedtime administration of valsartan. J. Hypertens. 2005a; 23: 1913–1922
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, López J E. Decrease in urinary albumin excretion associated to the normalization of nocturnal blood pressure in hypertensive subjects. Hypertension 2005b; 46: 960–968
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, Rodríguez M, Chayán L, López J E, Fontao M J, Soler R, Fernández J R. Administration‐time‐dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol. Int. 2005c; 22: 755–776
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Calvo C, Portaluppi F, Smolensky M H. Chronotherapy of hypertension: Administration‐time‐dependent effects of treatment on the circadian pattern of blood pressure. Adv. Drug Deliv. Rev. 2007a; 59: 923–939
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Fernández J R, Calvo C. Comparison of the efficacy of morning versus evening administration of telmisartan in essential hypertension. Hypertension 2007b; 50: 715–722
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Portaluppi F. Circadian variation of blood pressure. Adv. Drug Deliv. Rev. 2007c; 59: 904–922
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, López J E, Rodríguez M, Chayán L, Mojón A, Fontao M J, Fernández J R. Dose and administration‐time‐dependent effects of nifedipine GITS on ambulatory blood pressure in hypertensive subjects. Chronobiol. Int. 2007d; 24: 471–493
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, López J E, Rodríguez M, Chayán L, Fontao M J, Soler R, Romero M L, Alonso I, Fernández J R. Reduction of cardiovascular morbidity by increasing the diurnal/nocturnal blood pressure ratio: The MAPEC study. J. Hypertens. 2007e; 25(2)S139–S140
   Google Scholar
• Hermida R C, Ayala D E, Mojón A, Chayán L, Domínguez M J, Fontao M J, Soler R, Alonso I, Fernández J R. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol. Int. 2008a; 25: 950–970
   PubMed Web of Science ®Google Scholar
• Hermida R C, Ayala D E, Mojón A, Fernández J R. Chronotherapy with nifedipine GITS in hypertensive patients: Improved efficacy and safety with bedtime dosing. Am. J. Hypertens. 2008b; 21: 948–954
   PubMed Web of Science ®Google Scholar
• Kario K, Pickering T G, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz J E, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 2003; 107: 1401–1406
   PubMed Web of Science ®Google Scholar
• Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10‐year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension 2005; 45: 240–245
   PubMed Web of Science ®Google Scholar
• Laeis P, Puchler K, Kirch W. The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. J. Hypertens. 2001; 19: S21–S32
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty A M, Kjeldsen S E, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder R E, Struijker H AJ, Zanchetti A. 2007 guidelines for the management of arterial hypertension.The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2007; 25: 1105–1187
   PubMed Web of Science ®Google Scholar
• Neutel J M. Clinical studies of CS‐866, the newest angiotensin II receptor antagonist. Am. J. Cardiol. 2001; 87: 37C–43C
   PubMed Web of Science ®Google Scholar
• Neutel J M, Elliot W J, Izzo J L, Chen C L, Masonson H N. Antihypertensive efficacy of olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure measurements. J. Clin. Hypertens. 2002; 4: 325–331
   PubMedGoogle Scholar
• O'Brien E, Sheridan J, O'Malley K. Dippers and non‐dippers. Lancet. 1988; 13: 397
   Google Scholar
• O'Brien E, Mee F, Atkins N, ÓMalley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens. 1991; 9(5)S25–S31
   Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24‐h blood pressure: The Ohasama study. J. Hypertens. 2002; 20: 2183–2189
   PubMed Web of Science ®Google Scholar
• Oparil S. Newly emerging pharmacologic differences in angiotensin II receptor blockers. Am. J. Hypertens. 2000; 13: 18S–24S
   PubMed Web of Science ®Google Scholar
• Oparil S, Silfani T N, Walker J F. Role of angiotensin receptor blockers as monotherapy in reaching blood pressure goals. Am. J. Hypertens. 2005; 18: 287–294
   PubMed Web of Science ®Google Scholar
• Pickering T G, Hall J E, Appel L J, Falkner B E, Graves J, Hill M N, Jones D W, Kurtz T, Sheps S G, Roccella E J. Recommendations for blood pressure measurement in humans and experimental animals, part 1: Blood pressure measurement in humans. Hypertension 2005; 45: 142–161
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky M H. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics, W B White. Humana Press, Totowa, NJ 2000; 79–118
   Google Scholar
• Portaluppi F, Touitou Y, Smolensky M H. Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 2008; 25: 999–1016
   PubMed Web of Science ®Google Scholar
• Smolensky M H, Hermida R C, Portaluppi F. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol. Int. 2007; 24: 171–181
   PubMed Web of Science ®Google Scholar
• Staessen J, Fagard R, Lijnen P, Thijs L, Vaa Hoof R., Amery A. Ambulatory blood pressure monitoring in clinical trials. J. Hypertens. 1991; 9(1)S13–S19
   Google Scholar
• Staessen J A, Thijs L, Fagard R, ÓBrien E T, Clement D, de Leeuw P W, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282: 539–546, for the Systolic Hypertension in Europe (Syst‐Eur) Trial Investigators.
   PubMed Web of Science ®Google Scholar
• Svensson P, de Faire U., Sleight P, Yusuf S, Östergren J. Comparative effects of ramipril on ambulatory and office blood pressures. A HOPE substudy. Hypertension 2001; 38: E28–E32
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801
   PubMed Web of Science ®Google Scholar